Coumarins at the Crossroads of Drug Development: Enzyme Modulation for Clinical Advances
Indian Journal of Clinical Biochemistry · 2026-10 · 41 (5) · 683-706
DOI: 10.1007/s12291-025-01331-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Journal of Clinical Biochemistry, online erschienen am 10.07.2025. Verfasst von Yasser Fakri Mustafa. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq.
ORCID-Profile: Yasser Fakri Mustafa
Zitieren
APA
Mustafa, Y. F. (2026). Coumarins at the Crossroads of Drug Development: Enzyme Modulation for Clinical Advances. Indian Journal of Clinical Biochemistry, 41(5), 683-706. https://doi.org/10.1007/s12291-025-01331-2
Vancouver
Mustafa YF. Coumarins at the Crossroads of Drug Development: Enzyme Modulation for Clinical Advances. Indian Journal of Clinical Biochemistry. 2026;41(5):683-706. doi:10.1007/s12291-025-01331-2
BibTeX
@article{Mustafa2026,
author = {Mustafa, Yasser Fakri},
title = {Coumarins at the Crossroads of Drug Development: Enzyme Modulation for Clinical Advances},
journal = {Indian Journal of Clinical Biochemistry},
year = {2026},
volume = {41},
number = {5},
pages = {683--706},
doi = {10.1007/s12291-025-01331-2}
}
EUVIMED